tiprankstipranks
Humana (DE:HUM)
NYSE:HUM
Germany Market
HUM
Humana
RESEARCH TOOLSreports

Humana (HUM) Stock Forecast & Price Target

16 Followers
See the Price Targets and Ratings of:

HUM Analyst Ratings

Hold
19Ratings
Hold
6 Buy
11 Hold
2 Sell
Based on 19 analysts giving stock ratings to
Humana
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

€238.84
▲(37.26% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is €238.84 with a high forecast of €379.18 and a low forecast of €167.66. The average price target represents a 37.26% change from the last price of €174.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"151":"€151","380":"€380","208.25":"€208.3","265.5":"€265.5","322.75":"€322.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":379.18065969,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€379.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":238.8389138888889,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€238.84</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":167.66491755,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€167.66</span>\n  </div></div>","useHTML":true}}],"tickPositions":[151,208.25,265.5,322.75,380],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,280,287.6292815146154,295.2585630292308,302.88784454384614,310.51712605846154,318.14640757307694,325.77568908769234,333.4049706023077,341.0342521169231,348.6635336315385,356.2928151461539,363.9220966607693,371.5513781753846,{"y":379.18065969,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,280,276.8337626068376,273.6675252136752,270.5012878205128,267.33505042735044,264.168813034188,261.00257564102566,257.83633824786324,254.67010085470085,251.50386346153846,248.33762606837607,245.17138867521368,242.0051512820513,{"y":238.8389138888889,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,280,271.3588398115385,262.71767962307695,254.0765194346154,245.43535924615384,236.7941990576923,228.15303886923078,219.51187868076926,210.8707184923077,202.22955830384615,193.58839811538462,184.9472379269231,176.30607773846157,{"y":167.66491755,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":201.316,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.041,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":214.416,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.434,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.811,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":238.655,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.63,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.994,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.248,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.392,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.75,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":202,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€379.18Average Price Target€238.84Lowest Price Target€167.66
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on DE:HUM
Lance Wilkes
Bernstein
Bernstein
€247.63→€365.42
Buy
110.01%
Upside
Assigned
06/03/26
Humana price target raised to $425 from $288 at BernsteinHumana price target raised to $425 from $288 at Bernstein
Truist Financial Analyst forecast on DE:HUM
David S Macdonald
Truist Financial
Truist Financial
€232.15→€275.14
Hold
58.13%
Upside
Assigned
06/01/26
Humana price target raised to $320 from $270 at TruistHumana price target raised to $320 from $270 at Truist
Barclays Analyst forecast on DE:HUM
Andrew Mok CFA
Barclays
Barclays
€154.77→€295.78
Hold
69.99%
Upside
Reiterated
05/26/26
Humana price target raised to $344 from $180 at BarclaysHumana price target raised to $344 from $180 at Barclays
UBS Analyst forecast on DE:HUM
A.J. Rice
UBS
UBS
€225.27→€275.14
Hold
58.13%
Upside
Reiterated
05/22/26
Humana price target raised to $320 from $262 at UBSHumana price target raised to $320 from $262 at UBS
Deutsche Bank Analyst forecast on DE:HUM
George Hill
Deutsche Bank
Deutsche Bank
€202.06→€379.18
Buy
117.92%
Upside
Upgraded
05/20/26
Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank
Mizuho Securities Analyst forecast on DE:HUM
Ann Hynes
Mizuho Securities
Mizuho Securities
€249.35→€288.04
Buy
65.54%
Upside
Reiterated
05/19/26
Humana price target raised to $335 from $290 at MizuhoHumana price target raised to $335 from $290 at Mizuho
Morgan Stanley Analyst forecast on DE:HUM
Erin Wright
Morgan Stanley
Morgan Stanley
€186.58
Sell
7.23%
Upside
Assigned
05/15/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Pyxis Oncology (NASDAQ: PYXS) and Candel Therapeutics (NASDAQ: CADL)
Piper Sandler Analyst forecast on DE:HUM
Jessica Tassan
Piper Sandler
Piper Sandler
€156.49→€218.39
Hold
25.51%
Upside
Reiterated
05/13/26
Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler
Raymond James Analyst forecast on DE:HUM
John Ransom
Raymond James
Raymond James
€197.76→€223.55
Buy
28.48%
Upside
Reiterated
05/01/26
Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James
J.P. Morgan Analyst forecast on DE:HUM
Lisa Gill
J.P. Morgan
J.P. Morgan
€154.77→€184
Hold
5.75%
Upside
Reiterated
05/01/26
Humana (HUM) Gets a Hold from J.P. Morgan
TD Cowen Analyst forecast on DE:HUM
Ryan Langston
TD Cowen
TD Cowen
€148.75→€181.42
Hold
4.27%
Upside
Assigned
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (NASDAQ: RNAC) and Humana (NYSE: HUM)
Oppenheimer Analyst forecast on DE:HUM
Michael Wiederhorn
Oppenheimer
Oppenheimer
€214.96→€223.55
Buy
28.48%
Upside
Reiterated
04/30/26
Humana price target raised to $260 from $250 at OppenheimerHumana price target raised to $260 from $250 at Oppenheimer
Goldman Sachs Analyst forecast on DE:HUM
Scott Fidel
Goldman Sachs
Goldman Sachs
€135.85→€167.66
Sell
-3.64%
Downside
Reiterated
04/30/26
Humana price target raised to $195 from $158 at Goldman SachsHumana price target raised to $195 from $158 at Goldman Sachs
Wells Fargo Analyst forecast on DE:HUM
Stephen Baxter
Wells Fargo
Wells Fargo
€195.18
Hold
12.17%
Upside
Reiterated
04/30/26
Wells Fargo Remains a Hold on Humana (HUM)
Bank of America Securities Analyst forecast on DE:HUM
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
€180.56→€229.57
Hold
31.94%
Upside
Reiterated
04/30/26
Humana Kept at Hold as Analyst Raises Price Target to $267 Amid Margin-Rebuild Focus and Uncertain Medical Cost Trends
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on DE:HUM
Lance Wilkes
Bernstein
Bernstein
€247.63→€365.42
Buy
110.01%
Upside
Assigned
06/03/26
Humana price target raised to $425 from $288 at BernsteinHumana price target raised to $425 from $288 at Bernstein
Truist Financial Analyst forecast on DE:HUM
David S Macdonald
Truist Financial
Truist Financial
€232.15→€275.14
Hold
58.13%
Upside
Assigned
06/01/26
Humana price target raised to $320 from $270 at TruistHumana price target raised to $320 from $270 at Truist
Barclays Analyst forecast on DE:HUM
Andrew Mok CFA
Barclays
Barclays
€154.77→€295.78
Hold
69.99%
Upside
Reiterated
05/26/26
Humana price target raised to $344 from $180 at BarclaysHumana price target raised to $344 from $180 at Barclays
UBS Analyst forecast on DE:HUM
A.J. Rice
UBS
UBS
€225.27→€275.14
Hold
58.13%
Upside
Reiterated
05/22/26
Humana price target raised to $320 from $262 at UBSHumana price target raised to $320 from $262 at UBS
Deutsche Bank Analyst forecast on DE:HUM
George Hill
Deutsche Bank
Deutsche Bank
€202.06→€379.18
Buy
117.92%
Upside
Upgraded
05/20/26
Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank
Mizuho Securities Analyst forecast on DE:HUM
Ann Hynes
Mizuho Securities
Mizuho Securities
€249.35→€288.04
Buy
65.54%
Upside
Reiterated
05/19/26
Humana price target raised to $335 from $290 at MizuhoHumana price target raised to $335 from $290 at Mizuho
Morgan Stanley Analyst forecast on DE:HUM
Erin Wright
Morgan Stanley
Morgan Stanley
€186.58
Sell
7.23%
Upside
Assigned
05/15/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Pyxis Oncology (NASDAQ: PYXS) and Candel Therapeutics (NASDAQ: CADL)
Piper Sandler Analyst forecast on DE:HUM
Jessica Tassan
Piper Sandler
Piper Sandler
€156.49→€218.39
Hold
25.51%
Upside
Reiterated
05/13/26
Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler
Raymond James Analyst forecast on DE:HUM
John Ransom
Raymond James
Raymond James
€197.76→€223.55
Buy
28.48%
Upside
Reiterated
05/01/26
Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James
J.P. Morgan Analyst forecast on DE:HUM
Lisa Gill
J.P. Morgan
J.P. Morgan
€154.77→€184
Hold
5.75%
Upside
Reiterated
05/01/26
Humana (HUM) Gets a Hold from J.P. Morgan
TD Cowen Analyst forecast on DE:HUM
Ryan Langston
TD Cowen
TD Cowen
€148.75→€181.42
Hold
4.27%
Upside
Assigned
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (NASDAQ: RNAC) and Humana (NYSE: HUM)
Oppenheimer Analyst forecast on DE:HUM
Michael Wiederhorn
Oppenheimer
Oppenheimer
€214.96→€223.55
Buy
28.48%
Upside
Reiterated
04/30/26
Humana price target raised to $260 from $250 at OppenheimerHumana price target raised to $260 from $250 at Oppenheimer
Goldman Sachs Analyst forecast on DE:HUM
Scott Fidel
Goldman Sachs
Goldman Sachs
€135.85→€167.66
Sell
-3.64%
Downside
Reiterated
04/30/26
Humana price target raised to $195 from $158 at Goldman SachsHumana price target raised to $195 from $158 at Goldman Sachs
Wells Fargo Analyst forecast on DE:HUM
Stephen Baxter
Wells Fargo
Wells Fargo
€195.18
Hold
12.17%
Upside
Reiterated
04/30/26
Wells Fargo Remains a Hold on Humana (HUM)
Bank of America Securities Analyst forecast on DE:HUM
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
€180.56→€229.57
Hold
31.94%
Upside
Reiterated
04/30/26
Humana Kept at Hold as Analyst Raises Price Target to $267 Amid Margin-Rebuild Focus and Uncertain Medical Cost Trends
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months
Michael WiederhornOppenheimer
Success Rate
25/39 ratings generated profit
64%
Average Return
+3.22%
Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 64.10% of your transactions generating a profit, with an average return of +3.22% per trade.
1 Year
Michael WiederhornOppenheimer
Success Rate
24/39 ratings generated profit
62%
Average Return
+6.23%
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +6.23% per trade.
2 Years
Michael WiederhornOppenheimer
Success Rate
30/39 ratings generated profit
77%
Average Return
+15.02%
Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +15.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
1
1
0
0
0
Buy
13
11
11
11
11
Hold
28
24
34
19
20
Sell
3
3
4
2
2
Strong Sell
0
0
0
0
0
total
45
39
49
32
33
In the current month, HUM has received 11 Buy Ratings, 20 Hold Ratings, and 2 Sell Ratings. HUM average Analyst price target in the past 3 months is 238.84.
Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is €5.92 with a range of €1.39 to €6.61. The previous quarter’s EPS was €8.88. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.
Next quarter’s earnings estimate for HUM is €5.92 with a range of €1.39 to €6.61. The previous quarter’s EPS was €8.88. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is €34.92B with a range of €34.44B to €35.55B. The previous quarter’s sales results were €34.13B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.
Next quarter’s sales forecast for HUM is €34.92B with a range of €34.44B to €35.55B. The previous quarter’s sales results were €34.13B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is DE:HUM’s average 12-month price target, according to analysts?
Based on analyst ratings, Humana’s 12-month average price target is 238.84.
    What is DE:HUM’s upside potential, based on the analysts’ average price target?
    Humana has 37.26% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Humana a Buy, Sell or Hold?
          Humana has a consensus rating of Hold, which is based on 6 buy ratings, 11 hold ratings and 2 sell ratings.
            What is Humana’s share price target?
            The average share price target for Humana is 238.84. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €379.18 ,and the lowest forecast is €167.66. The average share price target represents 37.26% Increase from the current price of €174.
              What do analysts say about Humana?
              Humana’s analyst rating consensus is a Hold. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of Humana?
                To buy shares of DE:HUM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.